A virtual presentation on “Ethics in Vaccine Development, Testing and Use Making a COVID-19 Vaccine” will be held on March 9, 2021 as part of the 2021 Demystifying Medicine Series.
The 2021 Demystifying Medicine Series, which is jointly sponsored by FAES and NIH, will begin January 12 and includes the presentation of patients, pathology, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students, clinicians and program managers, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students, fellows and staff are welcome, as well.
About the Speakers
Kizzmekia Corbett, PhD is a research fellow and the scientific lead for the Coronavirus Vaccines & Immunopathogenesis Team at the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases, Vaccine Research Center (VRC). She received a B.S. in Biological Sciences, with a secondary major in Sociology, in 2008 from the University of Maryland – Baltimore County, where she was a Meyerhoff Scholar and an NIH undergraduate scholar. She then enrolled at University of North Carolina at Chapel Hill, where she obtained her Ph.D. in Microbiology and Immunology in 2014. A viral immunologist by training, Dr. Corbett uses her expertise to propel novel vaccine development for pandemic preparedness. Appointed to the VRC in 2014, her work focuses on developing novel coronavirus vaccines, including mRNA-1273, a leading candidate vaccine against the virus that causes COVID-19. In response to the ongoing global COVID-19 pandemic, the vaccine concept incorporated in mRNA-1273 was designed by Dr. Corbett’s team from viral sequence data and rapidly deployed to industry partner, Moderna, Inc., for U.S. Food and Drug Administration (FDA)-approved Phase 1 clinical trial, which unprecedently began only 66 days from the viral sequence release. Following promising results in animal models and humans, mRNA-1273 is currently in Phase 3 clinical trial. Alongside mRNA-1273, Dr. Corbett’s team boasts a portfolio that also includes universal coronavirus vaccine concepts and novel therapeutic antibodies. Additionally, Dr. Corbett spent several years working on a universal influenza vaccine, which is slated for Phase 1 clinical trial. In all, she has 15 years of expertise studying dengue virus, respiratory syncytial virus, influenza virus and coronaviruses. Along with her research activities, Dr. Corbett is an active member of the NIH Fellows Committee and avid advocator of STEM education and vaccine awareness in the community. Combining her research goals with her knack for mentoring, Dr. Corbett aims to become an independent principal investigator.
Christine Grady, PhD is a nurse-bioethicist and a senior investigator who currently serves as the Chief of the Department of Bioethics. Dr. Grady has authored more than 175 papers in the biomedical and bioethics literature and authored or edited several books, including The Oxford Textbook of Clinical Research Ethics. She served from 2010-2017 as a Commissioner on the President’s Commission for the Study of Bioethical Issues. Her work is known internationally, and she has lectured widely on ethical issues in clinical research and clinical care, HIV disease, and nursing. She is an elected fellow of the Hastings Center and of the American Academy of Nursing, a senior research fellow at the Kennedy Institute of Ethics and an elected member of the National Academy of Medicine. She holds a BS in nursing and biology from Georgetown University, a MSN. in community health nursing from Boston College, and a PhD in philosophy from Georgetown University. She has participated in numerous intergovernmental task forces and is the recipient of several awards, including the NIH CEO Award in 2017, and the NIH Director’s Award in 2015 and 2017.
Please visit the NIH Demystifying Medicine website for more information.